Diagnostic and prognostic outcomes for men with prostate cancer detected through opportunistic, asymptomatic PSA testing or symptomatic presentation to primary care: The PC3 cohort study

The authors aimed to compare the diagnostic and prognostic outcomes of prostate cancer in men presenting with symptoms versus those detected through opportunistic, asymptomatic PSA testing. Their study found that symptomatic patients were more likely to be diagnosed with clinically significant prostate cancer, although there was no difference in the stage at diagnosis between the two groups. This suggests that while symptoms may lead to earlier detection of more severe cases, the overall stage of cancer at diagnosis remains similar.